Tumor necrosis factor-α (cachectin) and tumor necrosis factor-β (lymphotoxin) are two closely related proteins that share sequence homology of 34% in their amino acid sequence. Both mediators act on their target cells via the same receptors and, therefore, show similar, but not identical, biological effects. Under denaturing conditions TNF-α is a 17-kilodalton, nonglycosylated protein. The biologically active form of TNF-α is a trimer. Besides this soluble form of TNF-α, a 28-kilodalton membrane-bound form occurs on cell surfaces of TNF-producing cells, which may serve as a pool for soluble TNF-α and can be proteolytically cleaved from the cell surface. Different cells are shown to produce TNF-α: For example, macrophages, CD4+ T cells and NK cells after stimulation with lipopolysaccharides. Additionally, smooth muscle cells, polymorphonuclear neutrophils, astrocytes and a variety of tumor cell lines can produce TNF-α. TNF-α acts via two distinct cell surface receptors, which are called TNF receptor I, and TNF receptor II. These receptors can be identified on virtually all cell types except erythrocytes. Besides the cell-bound forms of TNF receptors, soluble forms are known to be capable of TNF-α binding. They compete, therefore, with the cell-bound forms and can inhibit the effects of TNF-α. Due to the occurrence of TNF-α receptors on nearly all cells, TNF-α demonstrates a wide variety of biological action. It has cytolytic and cytostatic effects on tumor cells and shows chemotactic activity on neutrophils. TNF-α is a growth factor for fibroblasts and stimulates the synthesis of collagenase and prostaglandin E2 bone resorption can be induced by TNF-α because it activates osteoclasts. TNF-α enhances the proliferation of T cells after stimulation with IL-2. In the absence of IL-2, TNF-α induces the proliferation and differentiation of β cells. References: Buck C, Gallati H, Pohlandt F, et al. Increased levels of tumor necrosis factor alpha (TNF-alpha) in tracheal aspirates of newborns with pneumonia. Infection. 1994; 22(4):238-241. PubMed 8002082 Herbelin A, Nguyen AT, Zingraff J, et al. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int. 1990; 37(1):116-125. PubMed 2299797 Jacob CO. Tumor necrosis factor alpha in autoimmunity: Pretty girl or old witch? Immunol Today. 1992; 13(4):122-125 (review). PubMed 1580993 Marano MA, Fong Y, Moldawer LL, et al. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet. 1990; 170(1):32-38. PubMed 2294627 Maury CP, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med. 1987; 166(4):1132-1137. PubMed 3309124

Tumor necrosis factor-α (cachectin) and tumor necrosis factor-β (lymphotoxin) are two closely related proteins that share sequence homology of 34% in their amino acid sequence. Both mediators act on their target cells via the same receptors and, therefore, show similar, but not identical, biological effects. Under denaturing conditions TNF-α is a 17-kilodalton, nonglycosylated protein. The biologically active form of TNF-α is a trimer. Besides this soluble form of TNF-α, a 28-kilodalton membrane-bound form occurs on cell surfaces of TNF-producing cells, which may serve as a pool for soluble TNF-α and can be proteolytically cleaved from the cell surface. Different cells are shown to produce TNF-α: For example, macrophages, CD4+ T cells and NK cells after stimulation with lipopolysaccharides. Additionally, smooth muscle cells, polymorphonuclear neutrophils, astrocytes and a variety of tumor cell lines can produce TNF-α. TNF-α acts via two distinct cell surface receptors, which are called TNF receptor I, and TNF receptor II. These receptors can be identified on virtually all cell types except erythrocytes. Besides the cell-bound forms of TNF receptors, soluble forms are known to be capable of TNF-α binding. They compete, therefore, with the cell-bound forms and can inhibit the effects of TNF-α. Due to the occurrence of TNF-α receptors on nearly all cells, TNF-α demonstrates a wide variety of biological action. It has cytolytic and cytostatic effects on tumor cells and shows chemotactic activity on neutrophils. TNF-α is a growth factor for fibroblasts and stimulates the synthesis of collagenase and prostaglandin E2 bone resorption can be induced by TNF-α because it activates osteoclasts. TNF-α enhances the proliferation of T cells after stimulation with IL-2. In the absence of IL-2, TNF-α induces the proliferation and differentiation of β cells. References: Buck C, Gallati H, Pohlandt F, et al. Increased levels of tumor necrosis factor alpha (TNF-alpha) in tracheal aspirates of newborns with pneumonia. Infection. 1994; 22(4):238-241. PubMed 8002082 Herbelin A, Nguyen AT, Zingraff J, et al. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int. 1990; 37(1):116-125. PubMed 2299797 Jacob CO. Tumor necrosis factor alpha in autoimmunity: Pretty girl or old witch? Immunol Today. 1992; 13(4):122-125 (review). PubMed 1580993 Marano MA, Fong Y, Moldawer LL, et al. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet. 1990; 170(1):32-38. PubMed 2294627 Maury CP, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med. 1987; 166(4):1132-1137. PubMed 3309124

Understanding the Highly Sensitive Tumor Necrosis Factor-Alpha (TNF-α) Test Tumor Necrosis Factor-Alpha (TNF-α) is a critical biomarker used in medical diagnostics and research, known for its role in regulating inflammation and the immune system. A highly sensitive TNF-α test provides accurate detection of this cytokine, aiding in the diagnosis and management of various health conditions. What Is TNF-α? TNF-α is a cytokine primarily produced by activated macrophages, though other cells can also secrete it. It plays a central role in: Promoting inflammation Coordinating immune responses Inducing programmed cell death (apoptosis) Why Is TNF-α Important? Clinical Applications Diagnosing and Monitoring Diseases TNF-α levels are useful for identifying and managing conditions such as: Autoimmune diseases (e.g., rheumatoid arthritis, inflammatory bowel disease) Chronic inflammatory conditions Infections, including sepsis Treatment Monitoring The test helps: Assess disease activity in chronic inflammatory disorders Monitor the effectiveness of anti-TNF therapies Guide treatment decisions, particularly for patients using TNF inhibitors Key Features of the Highly Sensitive TNF-α Test Sample Type: Blood (serum) Patient Preparation: No special preparation required Sensitivity: Detects lower concentrations of TNF-α for more precise results Interpreting TNF-α Levels Understanding test results requires consideration of the patient's overall health and symptoms: Elevated Levels: Suggest active inflammation and may indicate more severe disease activity. Extremely High Levels: In cases like sepsis, this may signal a life-threatening condition. Persistently High Levels in Therapy: Could indicate ineffective treatment with TNF inhibitors. Research Applications of TNF-α TNF-α remains a key focus in medical research for: Developing new therapies for autoimmune diseases Exploring anticancer potential Understanding inflammation and immune system mechanisms Conclusion The highly sensitive TNF-α test is a powerful tool in both clinical and research settings. It provides detailed insights into inflammatory and immune-related conditions, helping healthcare providers make informed decisions about diagnosis and treatment.

Urinary tungsten (W) provides an indication of recent or ongoing exposure to the metal, and endogenous detoxification to a lesser extent. W doesn’t have physiological functions in the body, and has low toxic potential with oral exposure. About 50% of W appears to be rapidly absorbed from gastrointestinal tract, and excretion from the body is primarily via the urinary route. W is highly absorbed via inhalation of dust and fumes. In the body W is antagonistic to the essential element molybdenum which is important for the conversion of sulfite to essential sulfate, and for the production of uric acid. Thereby, excess W may impair physiological reactions and be associated with sulfite sensitivity (wine, eggs, etc.) and/or low levels of uric acid in blood. Low uric acid is not necessarily consequential, but rather may be an indicator of functional molybdenum insufficiency. Most exposures to W are from foods, and tungstate salts that may contaminate drinking water. Unconfirmed information is suggestive that rice protein concentrates/rice-based gluten-free products may be contaminated with W during processing. If true, that might explain the higher levels of urine W after DMSA for autistic children who are commonly on gluten-free diets (unpublished observations, Doctor’s Data). Other sources of W include catalysts and reagents in biochemical analysis, fire and waterproof materials, industrial lubricants, and ash from incineration of sewage sludge; “biosolids” may also be used to fertilize crops and pastures. W is used for producing hard metals, which are used in rock drills and metal-cutting tools, and for production of ferrotungsten in the steel industry. W-containing compounds are used as filaments for incandescent lamps, bronzes in pigments, and as catalysts in the petroleum industry. Illness from low-level environmental or occupational W exposure has not been well documented. Little information is available regarding the toxicity of W. However, individuals occupationally exposed to W microparticles and/or fumes may develop serious lung disease known as “hard metal disease.” Chelation may acutely increase urinary excretion of W.